02 April 2020 | Views
Pankaj Patel, Chairman, Zydus Group talks about his company's contribution in fighting the COVID-19 situation
Image credit- youtube.com
"Zydus Cadila has initiated an accelerated research programme with multiple teams in India and Europe developing a vaccine for the novel coronavirus, 2019-nCoV (COVID-19) based on two approaches. The first approach deals with the development of a DNA vaccine against the major viral membrane protein responsible for the cell entry of the novel coronavirus. The second approach deals with the development of a live attenuated recombinant measles virus vectored vaccine against COVID-19. There is an urgent and pressing need to develop a safe and efficacious vaccine that can prevent the spread of this deadly virus. Our researchers are working to bring a speedy solution to this most devastating outbreak in recent times."
- Pankaj Patel, Chairman, Zydus Group